The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Anadin Analgesic Film-coated Tablets Aspirin 325mg Caffeine 15mg

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/148/001

Main Information

Trade NameAnadin Analgesic Film-coated Tablets Aspirin 325mg Caffeine 15mg
Active SubstancesAspirin
Dosage FormFilm-coated tablet
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/148/001

Group Information

ATC CodeN02BA Salicylic acid and derivatives
N02BA51 acetylsalicylic acid, combinations excl. psycholeptics


License statusAuthorised
Licence Issued10/01/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral sale in blister packs containing not more than 24 unit dosage forms. The indications should be for self-diagnosis and self-treatment. Promotion to the general public only for indications appropriate for self-diagnosis and self-treatment. Aspirin containing medicinal products should not be administered to subjects under 16 years of age unless specifically indicated by a healthcare professional.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back